Skip to content

Very Low Tidal Volume vs Conventional Ventilatory Strategy for One-lung Ventilation in Thoracic Anesthesia

Multicenter Randomized Trial on Protective Ventilation Versus Conventional Ventilation During OLV in Patients Undergoing Thoracic Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01504893
Enrollment
984
Registered
2012-01-06
Start date
2013-09-30
Completion date
2017-09-30
Last updated
2022-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Distress Syndrome

Keywords

One lung ventilation, PEEP, thoracic surgery, lobectomy and pneumonectomy, ARDS

Brief summary

The purpose of this study is to determine if a protective ventilatory strategy during one-lung ventilation (OLV) based on low tidal volume, PEEP and alveolar recruitment maneuver can reduce Acute Respiratory Distress Syndrome (ARDS) and Postoperative pulmonary complications (PPCs) after major pulmonary resection. Primary endpoint: Evaluation of postoperative ARDS incidence Secondary endpoint: Evaluation od PPC incidence and postoperative outcomes (other complications, unplanned Intensive Care Admission, hospital and ICU length of stay, in-hospital mortality)

Detailed description

Pulmonary postoperative complications (PPCs) are the most frequent adverse events after thoracic surgery. Acute respiratory distress syndrome (ARDS) is the most severe among PPCs. Injurious mechanical ventilation is a recognized risk factor associated with ARDS and PPCs after major thoracic surgery. International literature reports a wide use of tidal volume around 5-6 ml/kg predicted body weight (PBW) during one lung ventilation (OLV) but variable use of PEEP and alveolar recruitment maneuver (ARM). The aim of this multicenter, randomized, single blind study is to determine if a protective ventilatory strategy during OLV based on low tidal volume, PEEP and alveolar recruitment maneuver compared to conventional strategy can reduce ARDS and PPCs after major pulmonary resection. Primary outcome is the incidence of in-hospital ARDS. Secondary outcomes are in-hospital incidence of postoperative pulmonary complications (PPCs), major cardiovascular events, unplanned Intensive Care Unit admission, in-hospital length of stay and mortality RANDOMIZATION Patients are randomly assigned to receive protective or conventional OLV according to a computer-generated randomization list (1:1 ratio) before anesthesia induction. Patients are blinded to the treatment. Anesthesiologists and surgeons are unblinded to the treatment during the surgical procedure and the postoperative outcome assessment. MEASUREMENTS Intraoperative collection of ventilatory settings, airway pressures, arterial blood gases analysis at the following time points: T1: two lung ventilation in supine position before placing the patient in lateral decubitus; T2: 30 minutes after OLV start; T3: 60 minutes after OLV start; T4: 20 minutes after lobectomy/pneumonectomy (during OLV); T5: 15 minutes after ARM in supine position and during two lung ventilation. Postoperative data collection 1, 12, 24, 36, 48 hours after surgery and at discharge. Arterial blood gas analysis will be performed 1 hour after extubation and 24 and 72 hours after surgery (or in case of respiratory insufficiency).

Interventions

PROCEDUREProtective one lung ventilation

Low tidal volume, PEEP and alveolar recruitment maneuver

Sponsors

Azienda Ospedaliera S. Maria della Misericordia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients ≥ 18 years * ASA IV * Elective thoracotomies or thoracoscopic major lung resection surgery (lobectomy, bilobectomy, pneumonectomy)

Exclusion criteria

* Emergency surgery * Wedge resection or atypical resection * Non-resective lung surgery requiring OLV * Patients \< 18 years * BMI \< 20 and BMI \> 29 * Heart disease with ejection fraction \<50% and/or severe valvulopathy * Pulmonary hypertension * Renal failure requiring dialytic treatment * Drug addiction * Mental retardation, depression and psychiatric disease * Motor or sensory deficit * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Acute Respiratory Distress Syndrome (ARDS) incidenceHospital stay (7 days average expected)incidence of ARDS (%)

Secondary

MeasureTime frameDescription
In-hospital mortalityHospital stay (7 days average aspected)To determine mortality (%)
Postoperative complicationsHospital stay (7 days average expected)To determine how many patients (%) would have any postoperative complications
Postoperative pulmonary complications (PPCs)Hospital stay (7 days average expected)Incidence of PPCs (%)
Intensive Care Unit (ICU) Length of stayHospital stay (7 days average aspected)Length of stay in ICU (days)
Length of hospital stayHospital stay (7 days average expected)Duration of hospital length of stay
Unplanned Intensive Care Unit (ICU) admissionHospital stay (7 days average aspected)To determine how many patients would require an ICU admission (%)

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026